secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K/A
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0000950170-25-058837
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health extends note maturity to July 2025, reduces royalty balance by $1.09M via stock
--------------------------------------------------------------------------------

- Issued 1,290,000 shares to a royalty holder in exchange for $1,094,952 reduction in outstanding royalty balance.
- Entered Note Amendment with Streeterville Capital extending $6,220,812.50 secured promissory note maturity to July 20, 2025.
- Note Amendment dated January 29, 2025, includes wholly-owned subsidiary Napo Pharmaceuticals as co-borrower.
- Shares issued in the exchange rely on Section 3(a)(9) exemption from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/0000950170-25-058837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/jagx-20250129.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-058837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer